These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35406791)

  • 41. Structure, function, and regulation of insulin-degrading enzyme.
    Hulse RE; Ralat LA; Wei-Jen T
    Vitam Horm; 2009; 80():635-48. PubMed ID: 19251053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.
    Kuo WL; Gehm BD; Rosner MR
    Mol Endocrinol; 1991 Oct; 5(10):1467-76. PubMed ID: 1775131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exchange Broadening Underlies the Enhancement of IDE-Dependent Degradation of Insulin by Anionic Membranes.
    Zheng Q; Lee B; Kebede MT; Ivancic VA; Kemeh MM; Brito HL; Spratt DE; Lazo ND
    ACS Omega; 2022 Jul; 7(28):24757-24765. PubMed ID: 35874268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S.
    Sbardella D; Tundo GR; Coletta A; Marcoux J; Koufogeorgou EI; Ciaccio C; Santoro AM; Milardi D; Grasso G; Cozza P; Bousquet-Dubouch MP; Marini S; Coletta M
    Cell Mol Life Sci; 2018 Sep; 75(18):3441-3456. PubMed ID: 29594388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. No major role for insulin-degrading enzyme in antigen presentation by MHC molecules.
    Culina S; Mauvais FX; Hsu HT; Burgevin A; Guénette S; Moser A; van Endert P
    PLoS One; 2014; 9(2):e88365. PubMed ID: 24516642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-degrading enzyme is activated by the C-terminus of α-synuclein.
    Sharma SK; Chorell E; Wittung-Stafshede P
    Biochem Biophys Res Commun; 2015 Oct; 466(2):192-5. PubMed ID: 26343304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential efficacy of Lactobacillus casei IBRC_M10711 on expression and activity of insulin degrading enzyme but not insulin degradation.
    Neyazi N; Mohammadi Farsani T; Nouri Z; Ghahremani MH; Khorramizadeh MR; Tajerian R; Motevaseli E
    In Vitro Cell Dev Biol Anim; 2017 Jan; 53(1):12-19. PubMed ID: 27573410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin degrading enzyme (IDE) expressed by Chinese hamster ovary (CHO) cells is responsible for degradation of insulin in culture media.
    Louie S; Lakkyreddy J; Castellano BM; Haley B; Nguyen Dang A; Lam C; Tang D; Lang S; Snedecor B; Misaghi S
    J Biotechnol; 2020 Aug; 320():44-49. PubMed ID: 32526262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.
    González-Casimiro CM; Arribas-Rodríguez E; Fiz-López A; Casas J; Gutiérrez S; Tellería P; Novoa C; Rojo-Rello S; Tamayo E; Orduña A; Dueñas C; Bernardo D; Perdomo G
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.
    Kuo WL; Montag AG; Rosner MR
    Endocrinology; 1993 Feb; 132(2):604-11. PubMed ID: 7678795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme.
    Maianti JP; Tan GA; Vetere A; Welsh AJ; Wagner BK; Seeliger MA; Liu DR
    Nat Chem Biol; 2019 Jun; 15(6):565-574. PubMed ID: 31086331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome.
    Bennett RG; Hamel FG; Duckworth WC
    Endocrinology; 2000 Jul; 141(7):2508-17. PubMed ID: 10875252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review.
    Azam MS; Wahiduzzaman M; Reyad-Ul-Ferdous M; Islam MN; Roy M
    Pharm Res; 2022 Apr; 39(4):611-629. PubMed ID: 35378698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple allosteric sites are involved in the modulation of insulin-degrading-enzyme activity by somatostatin.
    Tundo GR; Di Muzio E; Ciaccio C; Sbardella D; Di Pierro D; Polticelli F; Coletta M; Marini S
    FEBS J; 2016 Oct; 283(20):3755-3770. PubMed ID: 27579517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural and functional characterization of pathogenic non- synonymous genetic mutations of human insulin-degrading enzyme by in silico methods.
    Shaik NA; Kaleemuddin M; Banaganapalli B; Khan F; Shaik NS; Ajabnoor G; Al-Harthi SE; Bondagji N; Al-Aama JY; Elango R
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):517-32. PubMed ID: 24059301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase.
    Bennett RG; Hamel FG; Duckworth WC
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1047-53. PubMed ID: 8048917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
    Bernstein HG; Ernst T; Lendeckel U; Bukowska A; Ansorge S; Stauch R; Have ST; Steiner J; Dobrowolny H; Bogerts B
    J Psychiatr Res; 2009 Sep; 43(13):1095-105. PubMed ID: 19394958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Yeast as a tractable genetic system for functional studies of the insulin-degrading enzyme.
    Kim S; Lapham AN; Freedman CG; Reed TL; Schmidt WK
    J Biol Chem; 2005 Jul; 280(30):27481-90. PubMed ID: 15944156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.